Lawrence F Eichenfield1,2, Amy S Paller3,4, Wynnis L Tom1,2, Jeffrey Sugarman5, Adelaide A Hebert6, Sheila Fallon Friedlander1,2, Elaine Siegfried7,8, Nanette Silverberg9,10, Kelly M Cordoro5,11. 1. Department of Dermatology, University of California, San Diego School of Medicine and Rady Children's Hospital, San Diego, CA, USA. 2. Department of Pediatrics, University of California, San Diego School of Medicine and Rady Children's Hospital, San Diego, CA, USA. 3. Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 4. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 5. Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco, CA, USA. 6. Pediatric Dermatology, McGovern School of Medicine and Children's Memorial Hermann Hospital, Houston, TX, USA. 7. Department of Pediatrics, Saint Louis University School of Medicine, Cardinal Glennon Children's Hospital, St. Louis, MO, USA. 8. Department of Dermatology, Saint Louis University School of Medicine, Cardinal Glennon Children's Hospital, St. Louis, MO, USA. 9. Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, NY, USA. 10. Department of Pediatrics, Icahn School of Medicine at Mt Sinai, New York, NY, USA. 11. Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Abstract
BACKGROUND/ OBJECTIVES: Childhood-onset psoriasis is a common skin disorder that has recently received increasing attention, particularly because of its significant medical, social, financial, and psychological burdens and its associated comorbidities. With limited data available and lack of standardized management guidelines for pediatric psoriasis, an expert panel desired to provide an updated critical overview and practical guidance for management of the affected population. METHODS: A panel of pediatric dermatologists with extensive experience in pediatric psoriasis defined and prioritized a core set of topics, performed an English-language literature review, prepared critical evaluations and presentations of topic areas, and carried out a consensus meeting and follow-up consensus manuscript. RESULTS: The summation of evolving perspectives in pediatric psoriasis includes epidemiology and natural history of the disease, precipitating factors and comorbidities, quality of life and burden of disease, clinical features and disease presentation, differential diagnosis, pathogenesis and treatment, including topical, photo, and systemic therapies. CONCLUSION: Pediatric psoriasis is an important immune-mediated inflammatory skin disease with potential for significant impact on affected individuals and their caregivers. Current state-of-the-art care is based primarily on experience and expert consensus, but pediatric data are accumulating and therapeutic options are rapidly evolving.
BACKGROUND/ OBJECTIVES: Childhood-onset psoriasis is a common skin disorder that has recently received increasing attention, particularly because of its significant medical, social, financial, and psychological burdens and its associated comorbidities. With limited data available and lack of standardized management guidelines for pediatric psoriasis, an expert panel desired to provide an updated critical overview and practical guidance for management of the affected population. METHODS: A panel of pediatric dermatologists with extensive experience in pediatric psoriasis defined and prioritized a core set of topics, performed an English-language literature review, prepared critical evaluations and presentations of topic areas, and carried out a consensus meeting and follow-up consensus manuscript. RESULTS: The summation of evolving perspectives in pediatric psoriasis includes epidemiology and natural history of the disease, precipitating factors and comorbidities, quality of life and burden of disease, clinical features and disease presentation, differential diagnosis, pathogenesis and treatment, including topical, photo, and systemic therapies. CONCLUSION: Pediatric psoriasis is an important immune-mediated inflammatory skin disease with potential for significant impact on affected individuals and their caregivers. Current state-of-the-art care is based primarily on experience and expert consensus, but pediatric data are accumulating and therapeutic options are rapidly evolving.
Authors: Finola M Bruins; Maartje R Van Acht; Inge M G J Bronckers; Hans M M Groenewoud; Elke M G J De Jong; Marieke M B Seyger Journal: Acta Derm Venereol Date: 2022-06-29 Impact factor: 3.875
Authors: Travis Frantz; Ellen G Wright; Esther A Balogh; Abigail Cline; Adrienne L Adler-Neal; Steven R Feldman Journal: Children (Basel) Date: 2019-11-05
Authors: C Bodemer; A Kaszuba; K Kingo; A Tsianakas; A Morita; E Rivas; P Papanastasiou; D Keefe; M Patekar; P Charef; L Zhang; S Cafoncelli; C Papavassilis Journal: J Eur Acad Dermatol Venereol Date: 2021-01-19 Impact factor: 6.166
Authors: Letícia Oba Galvão; Carmelia Matos Santiago Reis; Natália Lima Alves; Elisa Scandiuzzi Maciel Journal: An Bras Dermatol Date: 2022-02-08 Impact factor: 2.113